Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

The dispute dates to 2013 when Apple sought Masimo’s technology to install pulse oximetry on its watch. Email correspondence ...

Medtronic settled a lawsuit claiming its pulse oximeters may provide less accurate readings for people with darker skin pigmentation. Medtronic agreed to provide labels and brochures to California ...

Apple and Masimo are back in a California court this week for a bench ... the two companies in which the former alleges the ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

A US Court hearing the case of Apple Vs Masimo appear to have given Apple a two finger salute by awarding them US$250, the ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to take a look at where Masimo Corporation (NASDAQ:MASI) stands against ...

Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in ...

A Delaware jury has found smartwatch maker Masimo guilty of infringing Apple's Apple Watch patents on health technology, but ...